Ibrutinib-induced polyneuropathy: A case report.

Pınar CömertMurat AlbayrakAbdulkerim YıldızOsman ŞahinHacer Berna Afacan ÖztürkMerih Reis Aras

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

To the best of our knowledge, polyneuropathy as a unique side-effect of ibrutinib has not been previously reported. In addition to the well-known side effects of ibrutinib treatment, it should be kept in mind that polyneuropathy may also develop.

Keyphrases

chronic lymphocytic leukemia
healthcare
high glucose
diabetic rats
oxidative stress
endothelial cells